Document Detail


Inadequacy of the Janus kinase 2/signal transducer and activator of transcription signal transduction pathway to mediate episodic growth hormone-dependent regulation of hepatic CYP2C11.
MedLine Citation:
PMID:  15591245     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CYP2C11, the most commonly expressed hepatic cytochrome P450 isoform in male rats, is induced by the masculine "episodic" secretory growth hormone profile. A considerable number of reports have indicated that episodic growth hormone effects are mediated by the activation of the Janus kinase 2 (Jak2)/signal transducer and activator of transcription (Stat)5B signal transduction pathway. We observed that restoration of the normal masculine plasma growth hormone pulse in hypophysectomized male rats did indeed rapidly activate (phosphorylate) Jak2, shortly followed by activation and nuclear translocation of Stat5B. Infusion of a growth hormone pulse with an amplitude that was 10% of the normal height induced a dramatic overexpression of CYP2C11, had little effect activating Jak2, but induced a more rapid and greater accumulation of activated nuclear Stat5B. Restoration of a growth hormone pulse with an amplitude of only 1% of normal had little effect phosphorylating Jak2, activated and translocated to the hepatic nucleus approximately 70% of the normally induced levels of Stat5B, but had no inductive effect on CYP2C11. Last, the hypophysectomized male rat receiving no growth hormone replacement expressed 25 to 35% of normal concentrations of CYP2C11 despite no measurable activation of either Jak2 or Stat5B. These results raise concerns regarding the requisite role of the Jak2/Stat5B pathway in mediating episodic growth hormone regulation of CYP2C11. However, accumulation of activated extracellular signal-regulated kinase (ERK)1 and ERK2 were the only transducers measured in the study not affected by the 1% replacement pulse of growth hormone and were elevated 2- to 3-fold above normal when the pulse was renaturalized to 10% of physiological amplitude, suggesting the possible involvement of mitogen-activated protein kinase in episodic growth hormone regulation of CYP2C11.
Authors:
Ashish S Verma; Ravindra N Dhir; Bernard H Shapiro
Related Documents :
19049975 - Foxo1 inhibits leptin regulation of pro-opiomelanocortin promoter activity by blocking ...
12562765 - Ataxia telangiectasia mutated proteins, mapks, and rsk2 are involved in the phosphoryla...
15115615 - Erk1/2 contributes negative regulation to stat3 activity in hss-transfected hepg2 cells.
9169915 - Signal transduction pathways activated by ciliary neurotrophic factor and related cytok...
18055465 - C-met inhibitors with novel binding mode show activity against several hereditary papil...
12714335 - Antioxidants attenuate myocyte apoptosis and improve cardiac function in chf: associati...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.     Date:  2004-12-09
Journal Detail:
Title:  Molecular pharmacology     Volume:  67     ISSN:  0026-895X     ISO Abbreviation:  Mol. Pharmacol.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-02-18     Completed Date:  2005-04-12     Revised Date:  2012-06-05    
Medline Journal Info:
Nlm Unique ID:  0035623     Medline TA:  Mol Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  891-901     Citation Subset:  IM    
Affiliation:
Laboratories of Biochemistry, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce St., Philadelphia, PA 19104-6048, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aryl Hydrocarbon Hydroxylases / genetics*
Blotting, Northern
DNA-Binding Proteins / physiology*
Gene Expression Profiling
Gene Expression Regulation, Enzymologic / drug effects*
Growth Hormone / pharmacology*
Hypophysectomy
Janus Kinase 2
Liver / drug effects,  enzymology*,  physiology
Male
Milk Proteins
Mitogen-Activated Protein Kinase 1 / metabolism
Mitogen-Activated Protein Kinase 3 / metabolism
Phosphorylation
Protein-Tyrosine Kinases / metabolism*
Proto-Oncogene Proteins / metabolism*
Rats
Rats, Sprague-Dawley
Reverse Transcriptase Polymerase Chain Reaction
STAT5 Transcription Factor
Signal Transduction / drug effects,  physiology*
Steroid 16-alpha-Hydroxylase / genetics*
Trans-Activators / physiology*
Grant Support
ID/Acronym/Agency:
GM45758/GM/NIGMS NIH HHS
Chemical
Reg. No./Substance:
0/DNA-Binding Proteins; 0/Milk Proteins; 0/Proto-Oncogene Proteins; 0/STAT5 Transcription Factor; 0/Stat5b protein, rat; 0/Trans-Activators; 9002-72-6/Growth Hormone; EC 1.14.14.1/Aryl Hydrocarbon Hydroxylases; EC 1.14.14.1/CYP2C11 protein, rat; EC 1.14.14.1/Steroid 16-alpha-Hydroxylase; EC 2.7.10.1/Janus Kinase 2; EC 2.7.10.1/Protein-Tyrosine Kinases; EC 2.7.10.2/Jak2 protein, rat; EC 2.7.11.24/Mitogen-Activated Protein Kinase 1; EC 2.7.11.24/Mitogen-Activated Protein Kinase 3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes.
Next Document:  Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core ...